Journal Article

Antibiotic Resistance: Lessons for the Future

Robert C. Moellering

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 27, issue Supplement_1, pages S135-S140
Published in print August 1998 | ISSN: 1058-4838
Published online August 1998 | e-ISSN: 1537-6591 | DOI:
Antibiotic Resistance: Lessons for the Future

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology


Show Summary Details


It is clear that emergence of resistant bacterial strains will continue to be a problem as long as clinicians use the currently available antimicrobial agents. Past and current policies for dealing with resistance have, at best, been only partially effective. Thus, novel approaches to the problem of antimicrobial resistance are badly needed. Development of novel “classic” antimicrobial agents, chemical modification of currently known agents to overcome resistance, and the development of potentiators of known antimicrobials represent three areas that have been partially exploited in the past and continue to represent fertile fields for additional investigation. In addition, a number of investigators are working to develop inhibitors of new bacterial targets and to develop inhibitors of genes relating to virulence or pathogenesis. Although the deployment of antisense nucleotides as antimicrobial agents is theoretically appealing, to date, it has not been possible to develop any of these agents for clinical use.

Journal Article.  0 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.